Literature DB >> 23123655

The use of Resolor (prucalopride) for chronic constipation in women.

Sue Woodward1.   

Abstract

Chronic constipation is a common problem among women, is associated with anxiety and depression and can adversely affect quality of life (Mason et al, 2002). Chronic constipation is often unrelieved by simple laxatives, dietary manipulation or lifestyle modification, with other specialist treatment options being invasive and often not widely available. More recently attention has turned to newer prokinetic agents, such as prucalopride (Resolor®), which increase gut motility and intestinal transit, for the relief of chronic constipation. While these are not effective for everyone, there is evidence that prucalopride can increase bowel frequency, relieve bothersome symptoms associated with constipation and improve quality of life for women who have failed to achieve satisfactory relief from two other laxatives (National Institute for Health and Clinical Excellence).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123655     DOI: 10.12968/bjon.2012.21.16.982

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  1 in total

1.  Factors predictive of treatment-emergent adverse events of prucalopride: an integrated analysis of four randomized, double-blind, placebo-controlled trials.

Authors:  Somchai Leelakusolvong; MeiYun Ke; Duowu Zou; Suck Chei Choi; Jan Tack; Eamonn M M Quigley; Andy Liu; Jin Yong Kim
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.